You have some very good points. The only levera

You have some very good points.

The only leverage i see at this point is you can have multiple interested parties do some kind of bidding (on ESS) for the JV that amarantus seeks and the highest bidder gets the JV. (I meant one JV partner to answer your question).

Maybe i'm thinking to simple but thats how i would play my cards.

I agree with you that we are in a weak position because of the toxics. Hopefully we get a decent/good JV that we have enough money to buy out the toxics so we can see some share appreciation.

I also agree that if we started trials and produced some good/promising data along the way then you would have better leverage and get a lot more attention from other companies to partner up.
But to get some good data i believe it will take a few months at least imo before any data is produced and analyzed.

I'm just not certain if we have sufficient money to do so, its hard for me to judge.

What i do recall is that they burn about $500K a month (also mentioned earlier on the board) so i think they really need some kind of financial injection before
they can start or else i don't think they can last long with the trials.

Hopefully we will hear some more news/details soon from ambs.

Thanks for your insights AA!